Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...

The filing of the legal action comes just a few days after J&J suffered a major setback in its defence in the US against ...

While the M&A emphasis is currently on life sciences, a business unit which sells products used in R&D and manufacturing ...

Debruyne has said that in recent years Bavarian Nordic has received several enquiries about a takeover but has never actively ...

There is an under-the-radar market access strategy that some manufacturers have implemented, but many others remain unaware ...

Novo Nordisk has bolstered its pipeline by paying $340 million upfront for rights to an Omeros Corp drug with potential ...

The global market for lipid nanoparticles (LNPs) hit $786 million in 2024 and is projected to grow 14% a year to 2030, driven ...

Interestingly, while only 16% of oncology researchers reported using AI in biomarker detection and assessment at the time of ...

Activist investor Shah Capital has called on the board of directors at Novavax to put the company up for sale, citing a ...

Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data ...

The results of the HER2CLIMB-05 show that Tukysa (tucatinib) improved progression-free survival (PFS) compared to placebo ...

The two-year Resilience programme, set up with £4.5 million ($6 million) in government funding last year, uses new tools such ...